Suppr超能文献

稳态趋化因子受体与器官特异性转移。

Homeostatic chemokine receptors and organ-specific metastasis.

机构信息

Department of Physiology and Biophysics, University of California, Irvine, California 92697, USA.

出版信息

Nat Rev Immunol. 2011 Aug 25;11(9):597-606. doi: 10.1038/nri3049.

Abstract

It has been 10 years since the role of a chemokine receptor, CXCR4, in breast cancer metastasis was first documented. Since then, the field of chemokines and cancer has grown significantly, so it is timely to review the progress, analyse the studies to date and identify future challenges facing this field. Metastasis is the major factor that limits survival in most patients with cancer. Therefore, understanding the molecular mechanisms that control the metastatic behaviour of tumour cells is pivotal for treating cancer successfully. Substantial experimental and clinical evidence supports the conclusion that molecular mechanisms control organ-specific metastasis. One of the most important mechanisms operating in metastasis involves homeostatic chemokines and their receptors. Here, we review this field and propose a model of 'cellular highways' to explain the effects of homeostatic chemokines on cancer cells and how they influence metastasis.

摘要

自首次记录趋化因子受体 CXCR4 在乳腺癌转移中的作用以来,已经过去了 10 年。从那时起,趋化因子与癌症领域的研究取得了显著进展,因此及时回顾这一领域的进展、分析迄今为止的研究并确定该领域面临的未来挑战非常重要。转移是大多数癌症患者生存的主要限制因素。因此,了解控制肿瘤细胞转移行为的分子机制对于成功治疗癌症至关重要。大量的实验和临床证据支持这样一个结论,即分子机制控制着器官特异性转移。在转移中起重要作用的机制之一涉及到稳态趋化因子及其受体。在这里,我们回顾了这一领域,并提出了一个“细胞高速公路”模型,以解释稳态趋化因子对癌细胞的影响,以及它们如何影响转移。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验